Skip to main content

Diagnosis and Management of Turner Syndrome in Children and Adults

  • Chapter
  • First Online:
Advanced Practice in Endocrinology Nursing

Abstract

Turner syndrome affects approximately 1 in 2500 live female births and is characterised by an abnormal or missing X chromosome. It is associated with increased morbidity and mortality due to the associated phenotypic abnormalities. The commonest presentation is aged 10–16 with short stature and primary amenorrhoea, however the considerable phenotypic variation some of which is associated with a particular/mosaic karyotype may lead to delay/missed diagnosis. Girls and women with TS should be followed up for life with screening for complications, and management of short stature, primary (and more rarely secondary) ovarian failure, cardiovascular complications, and increased autoimmune and metabolic risk. Recent guidelines provide useful guidance for the successful lifelong management of girls and women. A multidisciplinary approach addressing (Fig. 40.6) all aspects of their care including expert cardiological monitoring and intervention when required, access to fertility and obstetric expertise when appropriate, expert genetic counselling if indicated, and discussion of psychosocial, education, employment issues is key to the successful outcome for all women with Turner syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AMH:

Anti-Mullerian Hormone

APS:

Autoimmune polyglandular syndrome

ASI:

Aortic size index

BAV:

Bicuspid aortic valve

CMR:

Cardiac MRI

CoA:

Coarctation of aorta

ECG:

Electrocardiogram

GH:

Growth hormone

HRT:

Hormone replacement therapy

HTN:

Hypertension

IVF:

In vitro fertilisation

OR:

Odds ratio

R:

Recommendation of International Guidelines

SMR:

Standardised mortality ratio

TS:

Turner Syndrome

TTE:

Transthoracic echo

References

  • Allen DB. Safety of human growth hormone therapy: current topics. J Pediatr. 1996;128(5 Pt 2):S8–13.

    CAS  PubMed  Google Scholar 

  • Alvarez-Nava F, Lanes R, Quintero JM, Miras M, Fideleff H, Mericq V, et al. Effect of the parental origin of the X-chromosome on the clinical features, associated complications, the two-year-response to growth hormone (rhGH) and the biochemical profile in patients with turner syndrome. Int J Pediatr Endocrinol. 2013;2013(1):10.

    PubMed  PubMed Central  Google Scholar 

  • Atton G, Gordon K, Brice G, Keeley V, Riches K, Ostergaard P, et al. The lymphatic phenotype in Turner syndrome: an evaluation of nineteen patients and literature review. Eur J Hum Genet. 2015;23(12):1634–9.

    PubMed  PubMed Central  Google Scholar 

  • Bakalov VK, Gutin L, Cheng CM, Zhou J, Sheth P, Shah K, et al. Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun. 2012;38(4):315–21.

    PubMed  PubMed Central  Google Scholar 

  • Bannink EM, van der Palen RL, Mulder PG, de Muinck Keizer-Schrama SM. Long-term follow-up of GH-treated girls with Turner syndrome: BMI, blood pressure, body proportions. Horm Res. 2009a;71(6):336–42.

    CAS  PubMed  Google Scholar 

  • Bannink EM, van der Palen RL, Mulder PG, de Muinck Keizer-Schrama SM. Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences. Horm Res. 2009b;71(6):343–9.

    CAS  PubMed  Google Scholar 

  • Baxter L, Bryant J, Cave CB, Milne R. Recombinant growth hormone for children and adolescents with Turner syndrome. Cochrane Database Syst Rev. 2007;(1):CD003887.

    Google Scholar 

  • Becker B, Jospe N, Goldsmith LA. Melanocytic nevi in Turner syndrome. Pediatr Dermatol. 1994;11(2):120–4.

    CAS  PubMed  Google Scholar 

  • Bell J, Parker KL, Swinford RD, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab. 2010;95(1):167–77.

    CAS  PubMed  Google Scholar 

  • Birkebaek NH, Cruger D, Hansen J, Nielsen J, Bruun-Petersen G. Fertility and pregnancy outcome in Danish women with Turner syndrome. Clin Genet. 2002;61(1):35–9.

    CAS  PubMed  Google Scholar 

  • Bolar K, Hoffman AR, Maneatis T, Lippe B. Long-term safety of recombinant human growth hormone in turner syndrome. J Clin Endocrinol Metab. 2008;93(2):344–51.

    CAS  PubMed  Google Scholar 

  • Bondy CA. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92(1):10–25.

    CAS  PubMed  Google Scholar 

  • Bondy C. Pregnancy and cardiovascular risk for women with Turner syndrome. Womens Health (Lond). 2014;10(4):469–76.

    CAS  Google Scholar 

  • Bondy CA, Turner Syndrome Study Group. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92(1):10–25.

    CAS  PubMed  Google Scholar 

  • Bondy CA, Ceniceros I, Van PL, Bakalov VK, Rosing DR. Prolonged rate-corrected QT interval and other electrocardiogram abnormalities in girls with Turner syndrome. Pediatrics. 2006a;118(4):e1220–5.

    PubMed  Google Scholar 

  • Bondy CA, Ceniceros I, Lange E, Bakalov VK. Declining estrogen use in young women with Turner syndrome. Arch Intern Med. 2006b;166(12):1322.

    PubMed  Google Scholar 

  • Bondy C, Bakalov VK, Cheng C, Olivieri L, Rosing DR, Arai AE. Bicuspid aortic valve and aortic coarctation are linked to deletion of the X chromosome short arm in Turner syndrome. J Med Genet. 2013;50(10):662–5.

    PubMed  Google Scholar 

  • Bonnevie K. Embryoligical analysis of gene manifestation in Little and Bagg’s abnormal mouse tribe. J Exp Zool. 1934;67:443–520.

    Google Scholar 

  • Bosze P, Toth A, Torok M. Hormone replacement and the risk of breast cancer in Turner’s syndrome. N Engl J Med. 2006;355(24):2599–600.

    PubMed  Google Scholar 

  • Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update. 2014;20(5):688–701.

    CAS  PubMed  Google Scholar 

  • Calcaterra V, Gamba G, Montani N, de Silvestri A, Terulla V, Lanati G, et al. Thrombophilic screening in Turner syndrome. J Endocrinol Investig. 2011;34(9):676–9.

    CAS  Google Scholar 

  • Cameron-Pimblett A, King TFJ, La-Rosa C, Conway GS. Hypothyroidism is a risk factor for acquiring diabetes in women with Turner Syndrome. Endocr Abstr. 2017;50:OC3.2. https://doi.org/10.1530/endoabs.50.OC3.2.

    Article  Google Scholar 

  • Canonico M, Oger E, Plu-Bureau G, Conard J, Meyer G, Levesque H, et al. Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study. Circulation. 2007;115(7):840–5.

    CAS  PubMed  Google Scholar 

  • Carlson M, Airhart N, Lopez L, Silberbach M. Moderate aortic enlargement and bicuspid aortic valve are associated with aortic dissection in Turner syndrome: report of the international turner syndrome aortic dissection registry. Circulation. 2012;126(18):2220–6.

    PubMed  Google Scholar 

  • Carrascosa A, Gussinye M, Terradas P, Yeste D, Audi L, Vicens-Calvet E. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients. J Bone Miner Res. 2000;15(10):2005–10.

    CAS  PubMed  Google Scholar 

  • Cave CB, Bryant J, Milne R. Recombinant growth hormone in children and adolescents with Turner syndrome. Cochrane Database Syst Rev. 2003;(3):CD003887.

    Google Scholar 

  • Chrousos GA, Ross JL, Chrousos G, Chu FC, Kenigsberg D, Cutler G Jr, et al. Ocular findings in Turner syndrome. A prospective study. Ophthalmology. 1984;91(8):926–8.

    CAS  PubMed  Google Scholar 

  • Conway GS, Band M, Doyle J, Davies MC. How do you monitor the patient with Turner’s syndrome in adulthood? Clin Endocrinol. 2010;73(6):696–9.

    Google Scholar 

  • Culen C, Ertl DA, Schubert K, Bartha-Doering L, Haeusler G. Care of girls and women with Turner syndrome: beyond growth and hormones. Endocr Connect. 2017;6(4):R39–51.

    PubMed  PubMed Central  Google Scholar 

  • Davenport ML, Punyasavatsut N, Gunther D, Savendahl L, Stewart PW. Turner syndrome: a pattern of early growth failure. Acta Paediatr Suppl. 1999;88(433):118–21.

    CAS  PubMed  Google Scholar 

  • Davenport ML, Crowe BJ, Travers SH, Rubin K, Ross JL, Fechner PY, et al. Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007;92(9):3406–16.

    CAS  PubMed  Google Scholar 

  • Davenport ML, Roush J, Liu C, Zagar AJ, Eugster E, Travers S, et al. Growth hormone treatment does not affect incidences of middle ear disease or hearing loss in infants and toddlers with Turner syndrome. Horm Res Paediatr. 2010;74(1):23–32.

    CAS  PubMed  PubMed Central  Google Scholar 

  • dos Santos AP, Andrade JG, Piveta CS, de Paulo J, Guerra G Jr, de Mello MP, et al. Screening of Y chromosome microdeletions in 46,XY partial gonadal dysgenesis and in patients with a 45,X/46,XY karyotype or its variants. BMC Med Genet. 2013;14:115.

    PubMed  PubMed Central  Google Scholar 

  • Elsheikh M, Wass JA, Conway GS. Autoimmune thyroid syndrome in women with Turner’s syndrome—the association with karyotype. Clin Endocrinol. 2001a;55(2):223–6.

    CAS  Google Scholar 

  • Elsheikh M, Hodgson HJ, Wass JA, Conway GS. Hormone replacement therapy may improve hepatic function in women with Turner’s syndrome. Clin Endocrinol. 2001b;55(2):227–31.

    CAS  Google Scholar 

  • Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner’s syndrome in adulthood. Endocr Rev. 2002;23(1):120–40.

    CAS  PubMed  Google Scholar 

  • Fjermestad KW, Naess EE, Bahr D, Gravholt CH. A 6-year Follow-up survey of health status in middle-aged women with Turner syndrome. Clin Endocrinol. 2016;85(3):423–9.

    Google Scholar 

  • Flynn MT, Ekstrom L, De Arce M, Costigan C, Hoey HM. Prevalence of renal malformation in Turner syndrome. Pediatr Nephrol. 1996;10(4):498–500.

    CAS  PubMed  Google Scholar 

  • Frias JL, Davenport ML, Committee on Genetics and Section on Endocrinology. Health supervision for children with Turner syndrome. Pediatrics. 2003;111(3):692–702.

    PubMed  Google Scholar 

  • Gibbs P, Brady BM, Gonzalez R, Robinson WA. Nevi and melanoma: lessons from Turner’s syndrome. Dermatology. 2001;202(1):1–3.

    CAS  PubMed  Google Scholar 

  • Granger A, Zurada A, Zurada-Zielinska A, Gielecki J, Loukas M. Anatomy of turner syndrome. Clin Anat. 2016;29(5):638–42.

    PubMed  Google Scholar 

  • Gravholt CH, Poulsen HE, Ott P, Christiansen JS, Vilstrup H. Quantitative liver functions in Turner syndrome with and without hormone replacement therapy. Eur J Endocrinol. 2007;156(6):679–86.

    CAS  PubMed  Google Scholar 

  • Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177(3):G1–G70.

    CAS  PubMed  Google Scholar 

  • Gunther DF, Eugster E, Zagar AJ, Bryant CG, Davenport ML, Quigley CA. Ascertainment bias in Turner syndrome: new insights from girls who were diagnosed incidentally in prenatal life. Pediatrics. 2004;114(3):640–4.

    PubMed  Google Scholar 

  • Hadnott TN, Gould HN, Gharib AM, Bondy CA. Outcomes of spontaneous and assisted pregnancies in Turner syndrome: the U.S. National Institutes of Health experience. Fertil Steril. 2011;95(7):2251–6.

    PubMed  PubMed Central  Google Scholar 

  • Hart SJ, Davenport ML, Hooper SR, Belger A. Visuospatial executive function in Turner syndrome: functional MRI and neurocognitive findings. Brain. 2006;129(Pt 5):1125–36.

    PubMed  PubMed Central  Google Scholar 

  • Hewitt JK, Jayasinghe Y, Amor DJ, Gillam LH, Warne GL, Grover S, et al. Fertility in Turner syndrome. Clin Endocrinol. 2013;79(5):606–14.

    Google Scholar 

  • Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation. 2010;121(13):e266–369.

    PubMed  Google Scholar 

  • Hong DS, Reiss AL. Cognition and behavior in Turner syndrome: a brief review. Pediatr Endocrinol Rev. 2012;9(Suppl 2):710–2.

    PubMed  PubMed Central  Google Scholar 

  • Hook EB, Warburton D. Turner syndrome revisited: review of new data supports the hypothesis that all viable 45,X cases are cryptic mosaics with a rescue cell line, implying an origin by mitotic loss. Hum Genet. 2014;133(4):417–24.

    CAS  PubMed  Google Scholar 

  • Hughes IP, Choong CS, Harris M, Ambler GR, Cutfield WS, Hofman PL, et al. Growth hormone treatment for Turner syndrome in Australia reveals that younger age and increased dose interact to improve response. Clin Endocrinol. 2011;74(4):473–80.

    CAS  Google Scholar 

  • Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol. 2005;175(1):575–8.

    CAS  PubMed  Google Scholar 

  • Jacobs P, Dalton P, James R, Mosse K, Power M, Robinson D, et al. Turner syndrome: a cytogenetic and molecular study. Ann Hum Genet. 1997;61(Pt 6):471–83.

    CAS  PubMed  Google Scholar 

  • Kanaka-Gantenbein C. Hormone replacement treatment in Turner syndrome. Pediatr Endocrinol Rev. 2006;3(Suppl 1):214–8.

    PubMed  Google Scholar 

  • Kaplowitz PB, Chernausek SD, Horn JA. Fingernail angle in girls with Ullrich-Turner syndrome. Am J Med Genet. 1993;46(5):570–3.

    CAS  PubMed  Google Scholar 

  • Lanes R, Gunczler P, Esaa S, Martinis R, Villaroel O, Weisinger JR. Decreased bone mass despite long-term estrogen replacement therapy in young women with Turner’s syndrome and previously normal bone density. Fertil Steril. 1999;72(5):896–9.

    CAS  PubMed  Google Scholar 

  • Lim DB, Gault EJ, Kubba H, Morrissey MS, Wynne DM, Donaldson MD. Cholesteatoma has a high prevalence in Turner syndrome, highlighting the need for earlier diagnosis and the potential benefits of otoscopy training for paediatricians. Acta Paediatr. 2014;103(7):e282–7.

    CAS  PubMed  Google Scholar 

  • Linglart A, Cabrol S, Berlier P, Stuckens C, Wagner K, de Kerdanet M, et al. Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome. Eur J Endocrinol. 2011;164(6):891–7.

    CAS  PubMed  Google Scholar 

  • Lowenstein EJ, Kim KH, Glick SA. Turner’s syndrome in dermatology. J Am Acad Dermatol. 2004;50(5):767–76.

    PubMed  Google Scholar 

  • Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child. 1985;60(10):932–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Maraschio P, Tupler R, Barbierato L, Dainotti E, Larizza D, Bernardi F, et al. An analysis of Xq deletions. Hum Genet. 1996;97(3):375–81.

    CAS  PubMed  Google Scholar 

  • Marild K, Stordal K, Hagman A, Ludvigsson JF. Turner Syndrome and celiac disease: a case-control study. Pediatrics. 2016;137(2):e20152232.

    PubMed  Google Scholar 

  • Matura LA, Ho VB, Rosing DR, Bondy CA. Aortic dilatation and dissection in Turner syndrome. Circulation. 2007;116(15):1663–70.

    PubMed  Google Scholar 

  • Mortensen KH, Andersen NH, Gravholt CH. Cardiovascular phenotype in Turner syndrome—integrating cardiology, genetics, and endocrinology. Endocr Rev. 2012;33(5):677–714.

    CAS  PubMed  Google Scholar 

  • Nathwani NC, Unwin R, Brook CG, Hindmarsh PC. The influence of renal and cardiovascular abnormalities on blood pressure in Turner syndrome. Clin Endocrinol. 2000;52(3):371–7.

    CAS  Google Scholar 

  • Noto R, Maneatis T, Frane J, Alexander K, Lippe B, Davis DA. Intracranial hypertension in pediatric patients treated with recombinant human growth hormone: data from 25 years of the Genentech National Cooperative Growth Study. J Pediatr Endocrinol Metab. 2011;24(9–10):627–31.

    CAS  PubMed  Google Scholar 

  • Oktay K, Bedoschi G, Berkowitz K, Bronson R, Kashani B, McGovern P, et al. Fertility preservation in women with Turner Syndrome: a comprehensive review and practical guidelines. J Pediatr Adolesc Gynecol. 2016;29(5):409–16.

    PubMed  Google Scholar 

  • Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner’s syndrome. Italian Study Group for Turner’s Syndrome. J Clin Endocrinol Metab. 1997;82(6):1810–3.

    CAS  PubMed  Google Scholar 

  • Pessach IM, Notarangelo LD. X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J Autoimmun. 2009;33(1):17–24.

    CAS  PubMed  Google Scholar 

  • Pinsker JE. Clinical review: Turner syndrome: updating the paradigm of clinical care. J Clin Endocrinol Metab. 2012;97(6):E994–1003.

    CAS  PubMed  Google Scholar 

  • Quilter CR, Karcanias AC, Bagga MR, Duncan S, Murray A, Conway GS, et al. Analysis of X chromosome genomic DNA sequence copy number variation associated with premature ovarian failure (POF). Hum Reprod. 2010;25(8):2139–50.

    CAS  PubMed  Google Scholar 

  • Ranke MB, Lindberg A, Ferrandez Longas A, Darendeliler F, Albertsson-Wikland K, Dunger D, et al. Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS. Pediatr Res. 2007;61(1):105–10.

    CAS  PubMed  Google Scholar 

  • Rivkees SA. Ending the late diagnosis of Turner syndrome through a novel high-throughput assay. Pediatr Endocrinol Rev. 2012;9(Suppl 2):698–700.

    PubMed  Google Scholar 

  • Rivkees SA, Hager K, Hosono S, Wise A, Li P, Rinder HM, et al. A highly sensitive, high-throughput assay for the detection of Turner syndrome. J Clin Endocrinol Metab. 2011;96(3):699–705.

    CAS  PubMed  Google Scholar 

  • Rosenfeld RG, Attie KM, Frane J, Brasel JA, Burstein S, Cara JF, et al. Growth hormone therapy of Turner’s syndrome: beneficial effect on adult height. J Pediatr. 1998;132(2):319–24.

    CAS  PubMed  Google Scholar 

  • Ross J, Lee PA, Gut R, Germak J. Impact of age and duration of growth hormone therapy in children with Turner syndrome. Horm Res Paediatr. 2011a;76(6):392–9.

    CAS  PubMed  Google Scholar 

  • Ross JL, Quigley CA, Cao D, Feuillan P, Kowal K, Chipman JJ, et al. Growth hormone plus childhood low-dose estrogen in Turner’s syndrome. N Engl J Med. 2011b;364(13):1230–42.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Roulot D. Liver involvement in Turner syndrome. Liver Int. 2013;33(1):24–30.

    CAS  PubMed  Google Scholar 

  • Sachdev V, Matura LA, Sidenko S, Ho VB, Arai AE, Rosing DR, et al. Aortic valve disease in Turner syndrome. J Am Coll Cardiol. 2008;51(19):1904–9.

    PubMed  Google Scholar 

  • Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R, et al. Recommendations for the diagnosis and management of Turner syndrome. J Clin Endocrinol Metab. 2001;86(7):3061–9.

    CAS  PubMed  Google Scholar 

  • Schoemaker MJ, Swerdlow AJ, Higgins CD, Wright AF, Jacobs PA, United Kingdom Clinical Cytogenetics Group. Mortality in women with turner syndrome in Great Britain: a national cohort study. J Clin Endocrinol Metab. 2008;93(12):4735–42.

    CAS  PubMed  Google Scholar 

  • Sheanon NM, Backeljauw PF. Effect of oxandrolone therapy on adult height in Turner syndrome patients treated with growth hormone: a meta-analysis. Int J Pediatr Endocrinol. 2015;2015(1):18.

    PubMed  PubMed Central  Google Scholar 

  • Skuse DH, James RS, Bishop DV, Coppin B, Dalton P, Aamodt-Leeper G, et al. Evidence from Turner’s syndrome of an imprinted X-linked locus affecting cognitive function. Nature. 1997;387(6634):705–8.

    CAS  PubMed  Google Scholar 

  • Stephure DK, Canadian Growth Hormone Advisory Committee. Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial. J Clin Endocrinol Metab. 2005;90(6):3360–6.

    PubMed  Google Scholar 

  • Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH. Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab. 2006;91(10):3897–902.

    CAS  PubMed  Google Scholar 

  • Sutton EJ, Young J, McInerney-Leo A, Bondy CA, Gollust SE, Biesecker BB. Truth-telling and Turner Syndrome: the importance of diagnostic disclosure. J Pediatr. 2006;148(1):102–7.

    PubMed  Google Scholar 

  • Taboada M, Santen R, Lima J, Hossain J, Singh R, Klein KO, et al. Pharmacokinetics and pharmacodynamics of oral and transdermal 17beta estradiol in girls with Turner syndrome. J Clin Endocrinol Metab. 2011;96(11):3502–10.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Torres-Santiago L, Mericq V, Taboada M, Unanue N, Klein KO, Singh R, et al. Metabolic effects of oral versus transdermal 17beta-estradiol (E(2)): a randomized clinical trial in girls with Turner syndrome. J Clin Endocrinol Metab. 2013;98(7):2716–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Tuffli GA, Johanson A, Rundle AC, Allen DB. Lack of increased risk for extracranial, nonleukemic neoplasms in recipients of recombinant deoxyribonucleic acid growth hormone. J Clin Endocrinol Metab. 1995;80(4):1416–22.

    CAS  PubMed  Google Scholar 

  • Turner H. A syndrome of infantilism, congenital webbed neck and cubitus valgus. Endocrinology. 1938;23:566–78.

    Google Scholar 

  • Turtle EJ, Sule AA, Webb DJ, Bath LE. Aortic dissection in children and adolescents with Turner syndrome: risk factors and management recommendations. Arch Dis Child. 2015;100(7):662–6.

    CAS  PubMed  Google Scholar 

  • Ullrich O. Uber typische kombinationsbilder multipler abartungen. Z Kinderheilkunde Berlin. 1930;49:271–6.

    Google Scholar 

  • van Pareren YK, de Muinck Keizer-Schrama SM, Stijnen T, Sas TC, Jansen M, Otten BJ, et al. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. J Clin Endocrinol Metab. 2003;88(3):1119–25.

    PubMed  Google Scholar 

  • Vrablik M, Fait T, Kovar J, Poledne R, Ceska R. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins. Metabolism. 2008;57(8):1088–92.

    CAS  PubMed  Google Scholar 

  • Wihlborg CE, Babyn PS, Schneider R. The association between Turner’s syndrome and juvenile rheumatoid arthritis. Pediatr Radiol. 1999;29(9):676–81.

    CAS  PubMed  Google Scholar 

  • Wikiera B, Mulak M, Koltowska-Haggstrom M, Noczynska A. The presence of eye defects in patients with Turner syndrome is irrespective of their karyotype. Clin Endocrinol. 2015;83(6):842–8.

    CAS  Google Scholar 

  • Wilkins L, Fleischmann W. Ovarian agenesis: pathology, associated clinical symptoms and the bearing on the theories of sex differentiation. J Clin Endocrinol. 1944;39:204.

    Google Scholar 

  • Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736–54.

    PubMed  Google Scholar 

  • Wyatt D. Melanocytic nevi in children treated with growth hormone. Pediatrics. 1999;104(4 Pt 2):1045–50.

    CAS  PubMed  Google Scholar 

  • Zvulunov A, Wyatt DT, Laud PW, Esterly NB. Influence of genetic and environmental factors on melanocytic naevi: a lesson from Turner’s syndrome. Br J Dermatol. 1998;138(6):993–7.

    CAS  PubMed  Google Scholar 

Key Reading

  1. Bondy CA, Turner Syndrome Study Group. Care of girls and women with Turner syndrome: a guideline of the Turner Syndrome Study Group. J Clin Endocrinol Metab. 2007;92:10–25.

    CAS  PubMed  Google Scholar 

  2. Conway GS, Band M, Doyle J, Davies MC. How do you monitor the patient with Turner’s syndrome in adulthood? Clin Endocrinol (Oxf). 2010;73:696–9.

    Google Scholar 

  3. Culen C, Ertl DA, Schubert K, Bartha-Doering L, Haeusler G. Care of girls and women with Turner syndrome: beyond growth and hormones. Endocr Connect. 2017;6:R39–51.

    PubMed  PubMed Central  Google Scholar 

  4. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner’s syndrome in adulthood. Endocr Rev. 2002;23:120–40.

    CAS  PubMed  Google Scholar 

  5. Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, Sandberg DE, Sas TCJ, Silberbach M, Soderstrom-Anttila V, Stochholm K, van Alfen-van derVelden JA, Woelfle J, Backeljauw PF, International Turner Syndrome Consensus Group. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177:G1–G70.

    CAS  PubMed  Google Scholar 

  6. Bondy C. Pregnancy and cardiovascular risk for women with Turner syndrome. Womens Health (Lond). 2014;10:469–76.

    CAS  Google Scholar 

  7. Hewitt JK, Jayasinghe Y, Amor DJ, Gillam LH, Warne GL, Grover S, Zacharin MR. Fertility in Turner syndrome. Clin Endocrinol (Oxf). 2013;79:606–14.

    Google Scholar 

Download references

Acknowledgments

With special thanks to Arlene Smyth, Executive Officer, Turner Syndrome Support Society [UK] www.tss.org.uk for her contribution to this chapter with a case study and information on the Patient Advocacy Group.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Helen E. Turner .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Turner, H.E., Hozjan, I.R. (2019). Diagnosis and Management of Turner Syndrome in Children and Adults. In: Llahana, S., Follin, C., Yedinak, C., Grossman, A. (eds) Advanced Practice in Endocrinology Nursing. Springer, Cham. https://doi.org/10.1007/978-3-319-99817-6_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-99817-6_40

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-99815-2

  • Online ISBN: 978-3-319-99817-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics